InMode (154) Stock Forecast & Price Target

3 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

154 Analyst Ratings

Hold

0 Buy

4 Hold

0 Sell

Based on 4 analysts giving stock ratings to

InMode

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

154 Stock 12 Month Forecast

Average Price Target

€13.81

▲(4.01% Upside)

Based on 4 Wall Street analysts offering 12 month price targets for InMode in the last 3 months. The average price target is €13.81 with a high forecast of €14.68 and a low forecast of €12.95. The average price target represents a 4.01% change from the last price of €13.28.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"€10","15":"€15","11.25":"€11.25","12.5":"€12.5","13.75":"€13.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14.6755917,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€14.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.8123216,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€13.81</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.9490515,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€12.95</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,11.25,12.5,13.75,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.1,13.221199361538462,13.342398723076922,13.463598084615384,13.584797446153846,13.705996807692308,13.827196169230769,13.94839553076923,14.069594892307693,14.190794253846153,14.311993615384615,14.433192976923078,14.554392338461538,{"y":14.6755917,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.1,13.154793969230768,13.209587938461539,13.264381907692307,13.319175876923078,13.373969846153846,13.428763815384615,13.483557784615385,13.538351753846154,13.593145723076923,13.647939692307693,13.702733661538462,13.757527630769232,{"y":13.8123216,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.1,13.088388576923077,13.076777153846153,13.06516573076923,13.053554307692307,13.041942884615384,13.030331461538461,13.018720038461538,13.007108615384615,12.995497192307692,12.983885769230769,12.972274346153846,12.960662923076923,{"y":12.9490515,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11.745,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.54,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.425,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.66,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.13,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.375,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.885,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.435,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.68,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.71,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.795,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.96,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.1,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€14.68

Average Price Target€13.81

Lowest Price Target€12.95

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Caitlin Roberts

Canaccord Genuity

€12.95

Hold

-2.49%

Downside

Reiterated

08/17/26

Canaccord Genuity Reaffirms Their Hold Rating on InMode (INMD)

Michael Matson

Needham

―

Hold

―

Reiterated

08/05/26

Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), ImageneBio (NASDAQ: IMA) and InMode (NASDAQ: INMD)

Jeff Johnson

Robert W. Baird

€132.94→€14.68

Hold

10.51%

Upside

Reiterated

07/14/26

InMode price target lowered to $17 from $154 at BairdInMode price target lowered to $17 from $154 at Baird

Sam Eiber

BTIG

―

Hold

―

Assigned

07/10/26

Analyst Maintains Hold on InMode Amid Takeover Uncertainty and Limited Profitability Visibility

Matt Miksic

Barclays

€18.13→€16.4

Buy

23.51%

Upside

Reiterated

05/07/26

Barclays Sticks to Their Buy Rating for InMode (INMD)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€12.95

Hold

-2.49%

Downside

Reiterated

04/14/26

Jefferies Remains a Hold on InMode (INMD)

Danielle Antalffy

UBS

€14.03→€13.81

Hold

4.01%

Upside

Reiterated

11/06/25

InMode (INMD) Gets a Hold from UBS

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Caitlin Roberts

Canaccord Genuity

€12.95

Hold

-2.49%

Downside

Reiterated

08/17/26

Canaccord Genuity Reaffirms Their Hold Rating on InMode (INMD)

Michael Matson

Needham

―

Hold

―

Reiterated

08/05/26

Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), ImageneBio (NASDAQ: IMA) and InMode (NASDAQ: INMD)

Jeff Johnson

Robert W. Baird

€132.94→€14.68

Hold

10.51%

Upside

Reiterated

07/14/26

InMode price target lowered to $17 from $154 at BairdInMode price target lowered to $17 from $154 at Baird

Sam Eiber

BTIG

―

Hold

―

Assigned

07/10/26

Analyst Maintains Hold on InMode Amid Takeover Uncertainty and Limited Profitability Visibility

Matt Miksic

Barclays

€18.13→€16.4

Buy

23.51%

Upside

Reiterated

05/07/26

Barclays Sticks to Their Buy Rating for InMode (INMD)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€12.95

Hold

-2.49%

Downside

Reiterated

04/14/26

Jefferies Remains a Hold on InMode (INMD)

Danielle Antalffy

UBS

€14.03→€13.81

Hold

4.01%

Upside

Reiterated

11/06/25

InMode (INMD) Gets a Hold from UBS

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering InMode

3 Months

Matt MiksicBarclays

Success Rate

8/24 ratings generated profit

Average Return

-1.35%

Copying Matt Miksic's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -1.35% per trade.

1 Year

Matt MiksicBarclays

Success Rate

5/24 ratings generated profit

Average Return

-20.97%

Copying Matt Miksic's trades and holding each position for 1 Year would result in 20.83% of your transactions generating a profit, with an average return of -20.97% per trade.

2 Years

Matt MiksicBarclays

Success Rate

6/24 ratings generated profit

Average Return

-22.65%

Copying Matt Miksic's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -22.65% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

154 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 154 has received 0 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. 154 average Analyst price target in the past 3 months is 13.81.

Each month's total comprises the sum of three months' worth of ratings.

154 Financial Forecast

154 Earnings Forecast

Next quarter’s earnings estimate for 154 is €0.28 with a range of €0.24 to €0.29. The previous quarter’s EPS was €0.30. 154 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 154 has Performed in-line its overall industry.

154 Sales Forecast

Next quarter’s sales forecast for 154 is €79.40M with a range of €76.64M to €80.80M. The previous quarter’s sales results were €82.87M. 154 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 154 has Performed in-line its overall industry.

154 Stock Forecast FAQ

What is DE:154’s average 12-month price target, according to analysts?

Based on analyst ratings, InMode’s 12-month average price target is 13.81.

What is DE:154’s upside potential, based on the analysts’ average price target?

InMode has 4.01% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is InMode a Buy, Sell or Hold?

InMode has a consensus rating of Hold, which is based on 0 buy ratings, 4 hold ratings and 0 sell ratings.

What is InMode’s share price target?

The average share price target for InMode is 13.81. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €14.68 ,and the lowest forecast is €12.95. The average share price target represents 4.01% Increase from the current price of €13.28.

What do analysts say about InMode?

InMode’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of InMode?

To buy shares of DE:154, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

InMode (154) Stock Forecast & Price Target

154 Analyst Ratings

154 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering InMode

154 Analyst Recommendation Trends

154 Financial Forecast

154 Earnings Forecast

154 Sales Forecast

154 Stock Forecast FAQ

Detailed List of Analyst Forecasts